Norman D. Finch Jr. - 01 Mar 2026 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role: SVP, GC & Corporate Secretary
Signature: /s/ Caitlin Hippeli, as an agent for Norman Finch
Issuer symbol: WST
Transactions as of: 01 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 03 Mar 2026, 11:36:07 UTC
Previous filing: 10 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Finch Norman D. Jr.	SVP, GC & Corporate Secretary	530 HERMAN O. WEST DRIVE, EXTON	/s/ Caitlin Hippeli, as an agent for Norman Finch	03 Mar 2026	0001577064

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	WST	Rst. Stock Unit	Award	$0	+1,285		$0.000000	1,285	01 Mar 2026	Common Stock	1,285		Direct	F1, F2
transaction	WST	Stock Option (Right to Buy)	Award	$0	+3,057		$0.000000	3,057	01 Mar 2026	Common Stock	3,057	$254.34	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of WST common stock.
F2	The restricted stock units vest in four equal annual installments beginning on March 1, 2027.
F3	The stock option vests in four equal annual installments beginning on March 1, 2027.